These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36586454)

  • 1. Introduction to Special Issue on "Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases".
    Cuadrado A; Dinkova-Kostova AT; Mann GE
    Free Radic Biol Med; 2023 Feb; 195():258-260. PubMed ID: 36586454
    [No Abstract]   [Full Text] [Related]  

  • 2. The ethical imperative to treat NCDs during research in Africa.
    Mzombwe M; Desderius B; Kapiga S; Smart L; Peck R
    Lancet Glob Health; 2019 Apr; 7(4):e406-e407. PubMed ID: 30879500
    [No Abstract]   [Full Text] [Related]  

  • 3. The causal impact of ART on NCDs: leveraging quasi-experiments.
    Manne-Goehler J; Geldsetzer P; Bärnighausen T
    Lancet Diabetes Endocrinol; 2017 Jan; 5(1):14. PubMed ID: 28010784
    [No Abstract]   [Full Text] [Related]  

  • 4. Special Issue "Role of NRF2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches II".
    Lastres-Becker I
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SGLT2 inhibitors: A revolution in therapeutics of a Major Non-Communicable Disease.
    Khan MS
    J Pak Med Assoc; 2021 Apr; 71(4):1293. PubMed ID: 34125796
    [No Abstract]   [Full Text] [Related]  

  • 6. Translational control of Nrf2 within the open reading frame.
    Perez-Leal O; Barrero CA; Merali S
    Biochem Biophys Res Commun; 2013 Jul; 437(1):134-9. PubMed ID: 23806685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological stimulation of nuclear factor (erythroid-derived 2)-like 2 translation activates antioxidant responses.
    Perez-Leal O; Barrero CA; Merali S
    J Biol Chem; 2017 Aug; 292(34):14108-14121. PubMed ID: 28684421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2.
    Karathedath S; Rajamani BM; Musheer Aalam SM; Abraham A; Varatharajan S; Krishnamurthy P; Mathews V; Velayudhan SR; Balasubramanian P
    PLoS One; 2017; 12(5):e0177227. PubMed ID: 28505160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of long non-coding RNAs on the regulation of Nrf2 in chronic diseases.
    Jayasuriya R; Ramkumar KM
    Life Sci; 2021 Apr; 270():119025. PubMed ID: 33450255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways.
    Wardyn JD; Ponsford AH; Sanderson CM
    Biochem Soc Trans; 2015 Aug; 43(4):621-6. PubMed ID: 26551702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives from NHLBI Global Health Think Tank Meeting for Late Stage (T4) Translation Research.
    Engelgau MM; Peprah E; Sampson UKA; Mishoe H; Benjamin IJ; Douglas PS; Hochman JS; Ridker PM; Brandes N; Checkley W; El-Saharty S; Ezzati M; Hennis A; Jiang L; Krumholz HM; Lamourelle G; Makani J; Narayan KMV; Ohene-Frempong K; Straus SE; Stuckler D; Chambers DA; Belis D; Bennett GC; Boyington JE; Creazzo TL; de Jesus JM; Krishnamurti C; Lowden MR; Punturieri A; Shero ST; Young NS; Zou S; Mensah GA
    Glob Heart; 2017 Dec; 12(4):341-348. PubMed ID: 27452772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional polymorphisms in Nrf2: implications for human disease.
    Cho HY; Marzec J; Kleeberger SR
    Free Radic Biol Med; 2015 Nov; 88(Pt B):362-372. PubMed ID: 26117318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NRF2, a Transcription Factor for Stress Response and Beyond.
    He F; Ru X; Wen T
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32640524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low and high dose UVB regulation of transcription factor NF-E2-related factor 2.
    Kannan S; Jaiswal AK
    Cancer Res; 2006 Sep; 66(17):8421-9. PubMed ID: 16951152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaps in access to essential medicines and health products for noncommunicable diseases and mental health conditions.
    Minghui R; Simao M; Mikkelsen B; Kestel D; Ball A; Szilagyi Z
    Bull World Health Organ; 2020 Sep; 98(9):582-582A. PubMed ID: 33012854
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of economic sanctions on access to noncommunicable diseases medicines in the Islamic Republic of Iran.
    Kheirandish M; Varahrami V; Kebriaeezade A; Cheraghali AM
    East Mediterr Health J; 2018 Apr; 24(1):42-51. PubMed ID: 29658620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Service Readiness For Noncommunicable Diseases Was Low In Five Countries In 2013-15.
    Moucheraud C
    Health Aff (Millwood); 2018 Aug; 37(8):1321-1330. PubMed ID: 30080459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
    Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA
    PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncommunicable diseases in the Journal Ciência & Saúde Coletiva: a bibliometric study.
    Malta DC; Silva AGD; Cardoso LSM; Andrade FMD; Sá ACMGN; Prates EJS; Alves FTA; Xavier Junior GF
    Cien Saude Colet; 2020 Dec; 25(12):4757-4769. PubMed ID: 33295499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laminar flow activation of ERK5 protein in vascular endothelium leads to atheroprotective effect via NF-E2-related factor 2 (Nrf2) activation.
    Kim M; Kim S; Lim JH; Lee C; Choi HC; Woo CH
    J Biol Chem; 2012 Nov; 287(48):40722-31. PubMed ID: 23043106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.